Assess the Efficacy and Safety of Emerging Strategies That Impact Brain Cholesterol Turnover
Description
Expert faculty discuss the treatment landscape of pediatric patients with developmental and epileptic encephalopathies, such as Lennox-Gastaut syndrome and Dravet syndrome, and the emerging role of brain cholesterol in addressing seizure frequency as shown in the ELEKTRA clinical trial of soticlestat.